MedTrace Logo

Effect of Levetiracetam on Brain Excitability

NCT00006191 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 14

Last updated 2008-03-04

No results posted yet for this study

Summary

This study will examine the effect of the newly developed anti-epileptic drug, levetiracetam, on excitability of the cortex (surface layer) of the brain. Levetiracetam works differently from other anti-seizure drugs, but its mechanism is not well understood. This study may provide insight into a new protection mechanism against seizures as well as the effect of the drug on cortical excitability.

Healthy normal volunteers 18 years of age and older may be eligible for this study. Candidates will have a medical history taken and undergo physical and neurological examinations.

Participants will undergo two different procedures in four separate sessions. One procedure (cortical excitability) involves taking either levetiracetam or placebo (a look-alike inactive substance) and having transcranial magnetic stimulation (TMS). The other procedure (pinch-training related changes) involves taking levetiracetam or placebo, doing a motor exercise called pinch training, and having transcranial magnetic stimulation. For TMS, a very brief electrical current is passed through an insulated coil wire placed on the scalp. The magnetic pulse travels through the scalp and skull, causing small electrical currents in the cortex that may cause muscle, hand, or arm twitching or it may affect movements or reflexes. During the study, subjects may be asked to make movements, do simple tasks or tense muscles. Electrical activity of the muscles will be recorded using electrodes taped to the skin over the muscle. For the pinch training, the subject makes a brief, brisk pinch after each beat of a metronome every two seconds and then completely relaxes the hand until the next beat.

Subjects will be tested on four different days at least 72 hours apart. Each session will last about 3 to 4 hours.

Approximate schedule for cortical excitability testing:

TMS (study 1)

Take levetiracetam or placebo

TMS (study 2) \< 60 minutes after drug or placebo

TMS (study 3) \< 120 minutes after drug or placebo

Approximate schedule for pinch-training related changes:

Take levetiracetam or placebo

TMS and pinch power measurement \< 60 minutes after drug or placebo

Pinch training for 30 minutes

TMS and pinch power measurement

Sample schedule:

Session 1 \< LTC and cortical excitability testing

Session 2 \< Placebo and cortical excitability testing

Session 3 \< LTC and pinch-training related changes

Session 4 \< Placebo and pinch-training related changes

Conditions

  • Healthy
  • Myoclonic Epilepsy

Sponsors & Collaborators

  • National Institute of Neurological Disorders and Stroke (NINDS)

    lead NIH

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2000-08-31
Completion
2001-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00006191 on ClinicalTrials.gov